Profile
Radhakrishnan Maha is identified as a director on the board of Entrada Therapeutics, Inc., per the most recent SEC filing dated 2026-06-12. Publicly available SEC disclosures provide the director role but do not reveal additional details about his education, prior positions, or broader biographical background. He is listed in connection with Entrada Therapeutics as a board member, contributing to governance and oversight of the company’s strategic initiatives.
| Role | Insider |
|---|
| Notability | 60/100 |
|---|
Board memberships
- Entrada Therapeutics, Inc.
Awards & honors
- Board director of Entrada Therapeutics, Inc. (as identified in 2026 SEC filings)
Frequently Asked Questions
Who is Radhakrishnan Maha?
Radhakrishnan Maha is identified as a director on the board of Entrada Therapeutics, Inc., per the most recent SEC filing dated 2026-06-12. Publicly available SEC disclosures provide the director role but do not reveal additional details about his education, prior positions, or broader biographical background. He is listed in connection with Entrada Therapeutics as a board memb…
How many SEC Form 4 filings has Radhakrishnan Maha submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Radhakrishnan Maha's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.